Read Content Only
select font size Increase Font Size twelve pixels Increase Font Size fourteen pixels Increase Font Size sixteen pixels Email this link print page content

 

Bibliography of Original Articles Authored or Co-Authored by DGHE Research Faculty

2008:

1. Betancourt TS, Williams T. Building an evidence base on mental health interventions for children affected by armed conflict. International Journal of Mental Health, Psychosocial Work and Counselling in Areas of Armed Conflict. 2008;6(1):39-56.

2. Bukhman G, Kidder A. Cardiovascular disease and global health equity: lessons from tuberculosis control then and now. AJPH. 2008;98(1):44-54.

3. Castro, A. In and out: user fees and other unfortunate events during hospital admission and discharge [Entrando e saindo: honorários e outros contratempos na internação e alta hospitalares]. Cadernos Saúde Pública. 2008. 24(5):1174-1178. [Abstract in Portuguese; article in English]

4. Farmer P, Kim J. Surgery and Global Health: A View from Beyond the OR. World Journal of Surgery. 2008;32(4):533-536. [Published online 3 March 2008]

5. Ivers L, Garfein E, Augustin J, Raymonville M, Yang A, Sugarbaker D, Farmer P. Increasing Access to Surgical Services for the Poor in Rural Haiti: Surgery as a Public Good for Public Health. World Journal of Surgery. 2008;32(4):537-542. [Published online 5 March 2008]

6. Pape J, Farmer P, Koenig S, Fitzgerald D, Wright P, Johnson W. The epidemiology of AIDS in Haiti refutes the claims of Gilbert et al. [Letter]. PNAS. 2008;105(10):E13.

2007:

1. Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi WW, Fawzi MC. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):470-477.

2. Blaya JA, Shin SS, Yagui MJ, Yale G, Suarez CZ, Asencios LL, Cegielski JP, Fraser HS. A web-based laboratory information system to improve quality of care of tuberculosis patients in Peru: functional requirements, implementation and usage statistics. BMC Medical Informatics and Decision Making. 2007 Oct 28;7(1):33.

3. Bolton P, Bass J, Betancourt TS, Speelman L, Onyango G, Clougherty K, Neugebauer R, Murray L, Verdeli H. Interventions for depression symptoms among adolescent survivors of war and displacement in northern Uganda: a randomized controlled trial. JAMA. 2007;298(5):519-527.

4. Bukhman G, Schiller NB, Acquatella H. Endomyocardial fibrosis. In: Rose BD, editor. UpToDate. UpToDate, Waltham (MA):2007.

5. Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez WR. HIV viral load monitoring in resource-limited settings: optional or necessary? Clin Infect Dis. 2007;44(1):128-34.

6. Castro A, Khawja Y, González-Núñez I. Sexuality, reproduction, and HIV in women: the impact of ART in elective pregnancies in Cuba. AIDS 2007:21(S5):S49-S54.

7. Castro A, Westerhaus M. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements. Cadernos de Saúde Pública. 2007:23(S1):585-596.

8. Cheng X, Irimia D, Dixon M, Sekine K, Demirci U, Zamir L, Tompkins RG, Rodriguez W, Toner M. A microfluidic device for practical label-free CD4+ T cell counting of HIV-infected subjects. Lab Chip. 2007;7(2):170-78.

9. Cheng X, Irimia D, Dixon M, Ziperstein J, Demirci U, Zamir L, Tompkins RG, Toner M, Rodriguez W. A microchip approach for practical label-free CD4+ T cell counting of HIV-infected subjects in resource-poor settings. J Acquir Immune Defic Syndr. 2007;45(3):257-261.

10. Cheng X, Liu Y, Irimia D, Demirci U, Yang L, Zamir L, Rodriguez W, Toner M, Bashir R. Cell detection and counting through cell lysate impedance spectroscopy in microfluidic devices. Lab Chip. 2007;7(6):746-755.

11. Cohen T, Colijn C, Finklea B, Murray M. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. Journal of the Royal Society Interface. 2007;4(14):523-531.

12. Colijn C, Cohen T, Murray M. Emergent heterogeneity in declining tuberculosis epidemics. Journal of Theoretical Biology. 2007;247(4):765-774.

13. Farmer P. Una antropología de la violencia estructural: el caso de Haití. Temas. 2007;52 :63-73.

14. Furin J, Behforouz H, Shin SS, Mukherjee JS, Bayona J, Farmer PE, Kim JY, Keshavjee S. Expanding global HIV treatment: case studies from the field. Annals of the New York Academy of Science. 2007 Oct 22.

15. Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, Atwood S, Murray M. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bulletin of the World Health Organization. 2007;85(9):703-711.

16. Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL. Cytomegalovirus Retinitis: the neglected disease of the AIDS pandemic. PLoS Med 2007;4: e334.

17. Hirschhorn LR, Newell ML. Challenges and opportunities for expanding HIV care and treatment: what can be. Therapy. 2007;4(6):701-703.

18. Hirschhorn LR, Ojikutu B, Rodriguez W. Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings. J Infect Dis. 2007;196(3):S516-S522.

19. Keshavjee S, Gelmanova I, Pasechnikov A, Mushustin S, Andreev Y, Yedilbayev A, Furin J, Mukherjee JS, Rich M, Nardell E, Farmer PE, Kim JY, Shin SS. Treating multi-drug resistant tuberculosis in Tomsk, Russia: Developing programs that address the linkage between poverty and disease. Annals of the New York Academy of Science. 2007 Oct 22 epub ahead of print.

20. Kim JK. Toward a golden age: reflections on global health and social justice. Harvard International Review. Summer 2007;29(2):20-25.

21. Lipsitch M, Cohen T, Murray M, Levin BR. Antiviral resistance and the control of pandemic influenza. PLoS Medicine. 2007;4(1):e15.

22. Louis C, Ivers LC, Fawzi MC, Freedberg KA, Castro A. Late presentation for HIV care in central Haiti: factors limiting access to care. AIDS Care. 2007;19(4):487-491.

23. Mukherjee JS, Eustache E. Community health workers as a cornerstone for integrating HIV and primary healthcare. AIDS Care. 2007;19 Suppl 1:73-82.

24. Mukherjee JS. Structural violence, poverty and the AIDS pandemic. Development. 2007:15(1):115-121.

25. Nicholas PK, Mauceri L, Ciampa AS, Corless IB, Raymond N, Barry DJ, Ros AV. Distal Sensory Polyneuropathy in the Context of HIV/AIDS. J Assoc Nurses AIDS Care. 2007;18(4):32-40.

26. Rodriguez W. Antiretroviral treatment in resource-limited settings. In: Libman H, Makadon H, editors. HIV. 3rd edition. (American College of Physicians). New York: RSM Press, 2007:???-???

27. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007 Nov;11(12):1314-1320.

28. Smith Fawzi MC, Kaaya SF, Mbwambo J, Msamanga GI, Antelman G, Wei R, Hunter DJ, Fawzi WW. Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting. HIV Medicine. 2007 May;8(4):203-212.

29. Somocurcio J, Sotomayor A, Shin S, Portilla S, Valcarcel M, Guerra D, Furin JJ. Surgical therapy for patients with drug-resistant tuberculosis: report of 121 cases receiving community- based treatment in Lima, Peru. Thorax. 2007;62(5):416-421.

30. Victor TC, Streicher EM, Kewley C, Jordaan AM, van der Spuy GD, Bosman M, Louw H, Murray M, Young D, van Helden PD, Warren RM. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. International Journal of Tuberculosis and Lung Disease. 2007;11(2):195-201.

31. Westerhaus MJ, Finnegan AC, Zabulon Y, Mukherjee JS. Framing HIV prevention discourse to encompass the complexities of war in northern Uganda. American Journal of Public Health. 2007;97(7):1184-1186.

32. Wilson IB, Landon BE, Marsden PV, Hirschhorn LR, McInnes K, Ding L, Cleary PD. Correlations among measures of quality in HIV care in the United States: cross sectional study. BMJ. Published online 29 Oct 2007 [Online First].

33. Wolf LL, Ricketts P, Freedberg KA, Williams-Roberts H, Hirschhorn LR, Allen-Ferdinand K, Rodriguez WR, Divi N, Wong MT, Losina E. The cost-effectiveness of antiretroviral therapy for treating HIV disease in the Caribbean. J Acquir Immune Defic Syndr. 2007;46(4):463–471.

 

2006:

1. Abadía-Barrero C, Castro A. Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Social Science and Medicine. 2006;62(5):1219-1228.

2. Castro A. Ciencias sociales, medicina y salud pública: Un encuentro en torno al sida. Temas. 2006;47:15-21.

3. Chalco K, Wu DY, Mestanza L, Munoz M, Llaro K, Guerra D, Palacios E, Furin J, Shin S, Sapag R. Nurses as providers of emotional support to patients with MDR-TB. International Nursing Review. 2006;53(4):253-260.

4. Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. Proceedings of the National Academy of Sciences. 2006;103(18):7042-7047.

5. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006;117(6):2022-2029.

6. Ellis H, Rubin A, Betancourt TS, Saxe G. Mental health interventions for children affected by war or terrorism. In: Feerick M, Silverman GB, editors. Children Exposed to Violence. Baltimore (MD): Brookes Publishing, 2006:159-187.

7. Farmer PE, Nizeye B, Stulac S, Keshavjee S. Structural violence and clinical medicine. PLoS Medicine. 2006;3(10):e449.

8. Furin J, Farmer P, Wolf M, Levy B, Judd A, Paternek M, Hurtado R, Katz J. A novel training model to address health problems in poor and underserved populations. Journal of Health Care for the Poor and Underserved. 2006;17(1):17-24.

9. Gessler D, Dye C, Farmer P, Murray M, Navin T, Reves R, Shinnick T, Small P, Yates T, Simpson G. A national tuberculosis archive. Science. 2006;311(5765):1245-1246.

10. Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, Billman-Jacobe H, Lavender C, Fyfe J, Garcia-Garcia L, Leon CI, Bose M, Chaves F, Murray M, Eisenach KD, Sifuentes-Osornio J, Cave MD, Ponce de Leon A, Alland D. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2006;50(8):2640-2649.

11. Hohmuth BA, Yamanija JC, Dayal AS, Nardell E, Salazar JJ, Smith Fawzi MC. Latent tuberculosis infection: risks to health care students at a hospital in Lima, Peru. International Journal of Tuberculosis and Lung Disease. 2006 Oct;10(10):1146-1151.

12. Ivers LC, Mukherjee JS. Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings [research letter]. AIDS. 2006;20(5):779-780.

13. Ivers LC, Ryan ET. Infectious diseases of severe weather-related and flood-related natural disasters. Current Opinion in Infectious Diseases. 2006;19(5):408-414.

14. Johnson R, Warren R, Strauss OJ, Jordaan AM, Falmer AA, Beyers N, Schaaf HS, Murray M, Cloete K, van Helden PD, Victor TC. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. International Journal of Tuberculosis and Lung Disease. 2006;10(12):1412-1414.

15. Keshavjee S. Bleeding babies in Badakhshan: symbolism, materialism, and the political economy of traditional medicine in post-Soviet Tajikistan. Medical Anthropology Quarterly. 2006, 20(1):72-93.

16. Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, Young D, Victor TC. Frequency an the implications of pyrazinamide resistance in managing previously treated tuberculosis patients. International Journal of Tuberculosis and Lung Disease. 2006;10(7):802-807.

17. Mathew TA, Ovsyanikova TN, Shin SS, Gelmanova I, Balbuena DA, Atwood S, Peremitin GG, Strelis AK, Murray MB. Causes of death during tuberculosis treatment in Tomsk Oblast, Russia. International Journal of Tuberculosis and Lung Disease. 2006;10(8):857-863.

18. Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings: decreasing barriers to access and promoting adherence. Journal of Acquired Immune Deficiency Syndrome. 2006;43 Suppl 1:S123-S126.

19. Nardell EA, Mitnick CD. Are second-line drugs necessary to control multidrug-resistant tuberculosis? Journal of Infectious Diseases. 2006 Nov 1;194(9):1194-1196.

20. Nardell EA, Wallis RS. Here today—gone tomorrow: the case for transient acute tuberculosis infection. American Journal of Respiratory and Critical Care Medicine. 2006 Oct 1;174(7):734-735.

21. Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC. Multidrug-resistant tuberculosis management in resource-limited settings. Emerging Infectious Diseases. 2006:12(9):1389-1397.

22. Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Medicine. 2006;3(7):e241.

23. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug-susceptibility patterns for guiding design of retreatment regimens for MDR-TB. International Journal of Tuberculosis and Lung Disease. 2006;10(3):290-296.

24. Shin SS, Furin JJ, Alcantara F, Bayona J, Sanchez E, Mitnick CD. Long-term follow-up for multidrug-resistant tuberculosis. Emerging Infectious Diseases. 2006;12(4):687-688.

25. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. International Journal of Tuberculosis and Lung Disease. 2006;10(4):402-408.

26. Sivkov AI, Boldyrev AN, Azaev MSh, Bodnev SA, Medvedeva EV, Baranova OI, Ivlev-Dantau AP, Blinova LN, Pasechnikov AD, Tat'kov SI. [Evaluation of reasons of the MDR M. tuberculosis strains dissemination by analysis of the rifampicin and/or isoniazid resistant isolates][Article in Russian]. Mol Gen Mikrobiol Virusol. 2006;(2):20-25.

27. Smith Fawzi MC, Jagannathan P, Cabral J, Banares R, Salazar J, Farmer P, Behforouz H. Limitations in knowledge of HIV transmission among HIV-positive patients accessing case management services in a resource-poor setting. AIDS Care. 2006;18(7):764-771.

28. Smith Fawzi MC, Lambert W, Singler J, Léandre F, Nevil P, Bertrand D, Claude MS, Bertrand J, Louissaint M, Jeannis L, Cook EF, Salazar JJ, Farmer P, Mukherjee JS. Identification of chlamydia and gonorrhea among women in rural Haiti: maximizing access to treatment in a resource-poor setting. Sexually Transmitted Infections. 2006;82(2):175-181.

29. Somocurcio JG, Sotomayor A, Shin S, Portilla S, Valcarcel M, Guerra D, Furin J. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax. 2007 May;62(5):416-21.

30. Vasan A, Hoos D, Mukherjee JS, Farmer PE, Rosenfield AG, Perriëns JH. Pricing and procurement of antiretroviral drugs: Lessons from the Global Fund. Bulletin of the World Health Organization 2006;84(5):393-398.

31. Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Medicine 2006; 3(7):e241 (10 pages).

32. Westerhaus M, Castro A. A dismissal of global health: the threat of intellectual property rights and free trade agreements on access to antiretroviral therapy. PLoS Medicine 2006;3(8):e332 (7 pages).

33. Yagui M, Perales MT, Asencios L, Vergara L, Suarez C, Yale G, Salazar C, Saavedra M, Shin S, Ferrousier O, Cegielski P. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? International Journal of Tuberculosis and Lung Disease. 2006;19(8)838-843.

2005:

    1. Castro A, Farmer P. The impact of comprehensive HIV/AIDS care on stigma and testing: learnings and experiences from Haiti. Exchange on HIV/AIDS, Sexuality and Gender. 2005;1(1):30-31.
      1. In French: Castro A, Farmer P. L’impact des traitements complets pour le VIH/SIDA sur les stigmates et le dépistage: expériences haïtiennes. Échange sur le VIH/SIDA, la sexualité et le genre. 2005;1(1):30-31.
      2. In Portuguese: Castro A, Farmer P. O impacto do cuidado abrangente para HIV/SIDA sobre o estigma e a testagem. Intercâmbio sobre HIV/SIDA, sexualidade e gênero. 2005;1(1):30-31.
    2. Becerra MC, Pachao-Torreblanca IF, Bayona J, Celi R, Shin SS, Kim JY, Farmer PE, Murray M. Expanding tuberculosis case detection by screening household contacts. Public Health Reports. 2005;120(3):271-277.
    3. Betancourt T. Stressors, supports and the social ecology of displacement: psychosocial dimensions of an emergency education program for Chechen adolescents displaced in Ingushetia, Russia. Cult Med Psychiatry. 2005;29(3):309-340.
    4. Castro A. Adherence to antiretroviral therapy: Merging the clinical and social course of AIDS. PLoS Medicine. 2005; 2(12):e338.
    5. Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. American Journal of Public Health. 2005;95(1):53-59.
    6. Castro A, Farmer P. El estigma del SIDA y su evolución social: una visión desde Haití (AIDS-related stigma and its social course: a view from Haiti). Revista de Antropología Social. 2005;14():125-146.
    7. Cohen T, Murray M. Incident tuberculosis among recent US immigrants and exogenous reinfection. Emerging Infectious Diseases. 2005;11(5):725-728.
    8. Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph J, Furin, Shin S. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of six children with intrauterine exposure to second-line agents. Clinical Infectious Diseases. 2005;40(11):1689-1692.
    9. First MW, Weker RA, Yasui S, Nardell EA. Monitoring human exposures to upper-room germicidal ultraviolet irradiation. Journal of Occupational and Environmental Hygiene. 2005 May;2(5):285-92.
    10. Fraser HSF, Biondich P, Moodley D, Choi S, Mamlin BW, Szolovits P. Implementing electronic medical record systems in developing countries. Informatics in Primary Care. 2005;13(2):83-96.
    11. Gurjeva OS, Bukhman G, Murphy S, Cannon CP. Treatment and outcomes of Eastern Europeans Coronary Syndromes in OPUS-TIMI 16. International Journal of Cardiology. 2005;100(1):101-107.
    12. Han LL, Sloutsky A, Canales R, Naroditskaya V, Shin SS, Seung KJ, Timperi R, Becerra MC. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly-observed empiric retreatment with standardized regimens. International Journal of Tuberculosis and Lung Disease. 2005;9(7):818-821.
    13. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clinical Infectious Diseases. 2005;41(2):217-224.
    14. Kim JY, Shakow A, Mate K, Vanderwarker C, Gupta R, Farmer P. Limited good and limited vision: multidrug-resistant tuberculosis and global health policy. Social Science and Medicine. 2005;61(4):847-859.
    15. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HSF, Alarcon E, Cegielski JP, Grzemska M, Gupta R, Espinal M. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. 2005;9(6):640-645
    16. Novitskii VV, Strelis AK, Tkachenko SB, Esimova IE, Shil'ko TA, Urazova OI, Voronkova OV, Sinitsina VA, Filinyuk OV, Zemlyanaya NA. LPO and apoptosis during pulmonary tuberculosis. Bull Exp Biol Med. 2005;140(5):489-491.
    17. Paluzzi JE, Farmer PE. The wrong question. Development. 2005;48(1):12-18.
    18. Saravia JC, Appleton SC, Rich ML, Sarria M, Bayona J, Becerra MC. Re-treatment management strategies when first-line tuberculosis therapy fails. International Journal of Tuberculosis and Lung Disease. 2005;9(4):421-429.
    19. Shin S, Naroditskaya V, Sloutsky A, Werner B, Timperi R, Bayona J, Farmer P, Becerra M. rpoB gene mutations in clinical isolates in multidrug-resistant Mycobacterium tuberculosis in Northern Lima, Peru. Microbial Drug Resistance. 2005;11(1):26-30.
    20. Smith Fawzi MC, Lambert W, Singler JM, Tanagho Y, Léandre F, Nevil P, Bertrand D, Claude MS, Bertrand J, Louissaint M, Joanis L, Mukherjee JS, Goldie S, Salazar JJ, Farmer PE. Factors associated with forced sex among women in rural Haiti: implications for the prevention of HIV and other STDs. Social Science and Medicine. 2005;60(4):679-689.
    21. Solis L, Shin SS, Han LL, Llanos F, Stowell M, Sloutsky A. Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. International Journal of Tuberculosis and Lung Disease. 2005;9(7):760-764.
    22. Strelis AK, Peremitin GG, Ianova GV, Pavlova VE, Golubchikova VT, Ovsiannikova TN, Sirotkina OB, Tonkel TP, Strelis AA, Pasechnikov AD. Klin [Laboratory service optimization in the implementation of a complex programme for detection and treatment patients with tuberculosis][Article in Russian]. Lab Diagn. 2005;(4):38-40.
    23. Tat'kov SI, Norkina OV, Filipenko ML, Sivkov AIu, Boldyrev AN, Azaev MSh, Kinsht VN, Kurunov IuN, Krasnov VA, Medvedeva EV, Baranova OI, Ivlev-Duntau AP, Bodnev SA, Blinova LN, Pasechnikov AD. [Molecular and genetic characterization of rifampicin- and/or izoniazid-resistent strains of M. tuberculosis, isolated in Novosibirsk and Tomsk regions][Article in Russian]. Vestn Ross Akad Med Nauk. 2005;(7):26-36.
    24. Timperi R, Han LL, Sloutsky A, Becerra MC, Nardell EA, Salazar JJ, Smith-Fawzi MC. Drug-resistance profiles of Mycobacterium tuberculosis isolates: Five years’ experience and insight into treatment strategies for multidrug resistant tuberculosis in Lima, Peru. International Journal of Tuberculosis and Lung Disease. 2005;9(2):175-180.

2004:

1. Behforouz HL, Farmer PE, Mukherjee JS. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clinical Infectious Diseases. 2004;38(Suppl 5):S429-436.

2. Behforouz HL, Kalmus A, Scherz CS, Kahn JS, Kadakia MB, Farmer PE. Directly observed therapy for HIV antiretroviral therapy in an urban U.S. setting. Journal of Acquired Immune Deficiency Syndromes. 2004;36(1):642-645.

3. Bolton P, Betancourt TS. Mental health in postwar Afghanistan. JAMA. 2004;292(5):626-628.

4. Castro A. Farmer P. ¿Perlas del Caribe? La salud pública en Haití y en Cuba. Revista Colombiana de Antropología. 2004;40:319-352.

5. Chavez-Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD. Identifying early treatment failure on Category 1 therapy for pulmonary tuberculosis in Lima Ciudad, Peru. International Journal of Tuberculosis and Lung Disease. 2004;8:52-58.

6. Choi SS, Jazayeri DG, Mitnick CD, Chalco K, Bayona J, Fraser HS. Implementation and initial evaluation of a web-based nurse order entry system for multidrug-resistant tuberculosis patients in Peru. Medinfo. 2004;11(Part 1):202-206.

7. Cohen T, Becerra MC, Murray M. Isoniazid resistance and the future of drug-resistant tuberculosis. Microbial Drug Resistance. 2004;10(4):280-285.

8. Cohen T, Murray M. Modeling epidemics of multidrug-resistant tuberculosis of heterogeneous fitness [letter]. Nature Medicine. 2004;10(10):1117-1121.

9. Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G. Inhaling to mitigate exhaled bioaerosols. Proceedings of the National Academy of Sciences of the United States of America. 2004;101(50):17383-17388.

10. Farmer P, Gastineau Campos N. New malaise: bioethics and human rights in the global era. Journal of Law, Medicine, and Ethics. 2004;32(2):243-251.

11. Farmer P, Gastineau Campos N. Rethinking medical ethics: a view from below. Developing World Bioethics. 2004;4(1):17-41.

12. Farmer P. An anthropology of structural violence [delivered as the 2001 Sidney W. Mintz Lecture in Anthropology on November 27, 2001, at Johns Hopkins University]. Current Anthropology. 2004;45(3):305-326.

13. Farmer P. Political violence and public health in Haiti. New England Journal of Medicine. 2004;350(15):1483-1486.

14. Farmer PE, Furin JJ, Katz JT. Global health equity. Lancet. 2004;363(9423):1832.

15. Fine AM, Wong JB, Fraser HSF, Fleisher GR, Mandl KD. Is it influenza or anthrax? A decision analytic approach to the management of patients with influenza-like illnesses. Annals of Emergency Medicine. 2004;43(3):318-328.

16. Fraser HSF, Jazayeri D, Kempton K, Mosely M, Choi S, Pachao F, Bayona J. A system for modeling medication requirements for the management of drug resistant tuberculosis in developing countries. Medinfo. 2004;2004(CD):1603.

17. Fraser HSF, Jazayeri D, Nevil P, Karacaoglu Y, Farmer PE, Lyon E, Smith Fawzi MC, Léandre F, Choi S, Mukherjee JS. An information system and medical record to support HIV treatment in rural Haiti. British Medical Journal. 2004;329(7454):1142-1146.

18. Gupta R, Irwin A, Raviglione MC, Kim JY. Scaling up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis. Lancet. 2004;363:322-324.

19. Ivers LC, Kim AY, Sax PE. Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein-Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma. Clinical Infectious Diseases. 2004;38(11):1629-1632.

20. Ivers LC, Ryan ET. Vaccination strategies. Clinics in Occupational and Environmental Medicine. 2004;4(1):27-43.

21. Kapkov LP, Punga VV, Vasil'ev MI, Kazennyi BIa, Vorokhobkin IuS, Medvedeva OA, Peremitin GG. [Impact of introduction of the WHO tuberculosis-controlling recommendations adapted to the Russian conditions on the Russian statistical tuberculosis data][Article in Russian]. Probl Tuberk Bolezn Legk. 2004;(8):15-19.

22. Keshavjee S. Medicine and money: the ethical transformation in medical practice. Medical Education. 2004;38(3):271-275.

23. Kim JY. HIV/AIDS in the Eastern Mediterranean: a false immunity? La Revue de Sante de la Mediteranee Orientale. 2004;8(6):684-688.

24. Ko G, Thompson KM, Nardell EA. Estimation of tuberculosis risk on a commercial airliner. Risk Analysis. 2004 Apr;24(2):379-388.

25. Koenig SP, Léandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS. 2004;(18 Suppl 3):S21-25.

26. Kudva IT, Griffin RW, Murray M, John M, Perna NT, Barrett TJ, Calderwood SB. Insertions, deletions and single nucleotide polymorphisms at rare restriction enzyme sites enhance discriminatory power of polymorphic amplified typing sequences, a novel strain typing system for Escherichia coli O157:H7. Journal of Clinical Microbiology. 2004;42(6):2388-2397.

27. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Alcántara Virú F, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 2004;363(9407):474-481

28. Nardell EA, Fan D, Shepard JA, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22-2004. A 30-year-old woman with a pericardial effusion. New England Journal of Medicine. 2004 Jul 15;351(3):279-287.

29. Nathanson E, Gupta R, Huamani P, Leimane V, Pasechnikov AD, Tupasi TE, Vink K, Jaramillo E, Espinal MA. Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. International Journal of Tuberculosis and Lung Disease. 2004;8(11):1382-1384.

30. Paluzzi J, Farmer P. A tale of two viruses: social responses to AIDS and SARS. Brown Journal of World Affairs. 2004;10(2):199-206.

31. Paluzzi JE, Farmer PE. This is the house that Jack built: non-integrated health policies in an integrated world. Globalizations. 2004;1(1):111-119.

32. Paluzzi JE. A social disease/a social response: lessons in tuberculosis from 1930s Chile. Social Science and Medicine. 2004;59(4):763-773.

33. Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. International Journal of Tuberculosis and Lung Disease. 2004;8(3):361-368.

34. Seung KJ, Gelmanova IE, Peremitin GG, Golubchikova VT, Pavlova VE, Sirotkina OB, Yanova GV, Strelis AK. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clinical Infectious Diseases. 2004;39(9):1321-1328. Epub 2004 Oct 13.

35. Shin S, Furin J, Alcántara F, Hyson A, Joseph K, Sanchez E, Rich M. Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis. Chest. 2004;125(3):974-980.

36. Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer PE. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: seven years of experience. Social Science and Medicine. 2004;59(7):1529-1539.

37. Szot A, Jacobson F, Munn S, Jazayeri D, Nardell E, Harrison D, Drosten R, Ohno-Machado L, Smeaton LM, Fraser HSF. Diagnostic accuracy of chest x-rays acquired using a digital camera for low-cost teleradiology. International Journal of Medical Information. 2004;73(1):65-73.

38. Vásquez-Campos L, Asencios-Solis L, Leo-Hurtado E, Quispe-Torres N, Salazar-Lindo E, Bayona J, Becerra MC. Drug-resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001. International Journal of Tuberculosis and Lung Disease. 2004;8(4):465-472.

39. Vega P, Sweetland A, Acha J, Castillo H, Guerra D, Smith Fawzi MK, Shin S. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. 2004;8(6):749-759.

40. Walton DA, Farmer PE, Lambert W, Léandre F, Koenig SP, Mukherjee JS. Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti. Journal of Public Health Policy. 2004;25(2):137-158.

2003:

1. Alland D, Whittam T, Murray M, Cave DM, Hazbon M, Dix K, Kokoris M, Duesterhoeft A, Eisen JA, Fraser CM, Fleischmann RD. Modeling bacterial evolution with comparative-genome based marker systems: application to M. tuberculosis evolution and pathogenesis. Journal of Bacteriology. 2003;185(11):3392-3399.

2. Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. 2003;7:S501-509.

3. Blower S, Farmer P. Predicting the public health impact of antiretrovirals: preventing HIV in developing countries. AIDScience. 2003;3(11): online.

4. Blower S, Ma L, Farmer P, Koenig S. Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Current Drug Targets – Infectious Disorders. 2003;3(4):345-353.

5. Brickner PW, Vincent RL, First M, Nardell E, Murray M, Kaufman W. The application of ultraviolet germicidal irradiation to control transmission of airborne disease: bioterrorism countermeasure. [review] Public Health Reports. 2003 Mar-Apr;118(2):99-114.

6. Castro A, Farmer P. El SIDA y la violencia estructural: La culpabilización de la víctima. Cuadernos de Antropología Social. 2003;17:31-49.

7. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infectious Diseases. 2003;3(1):13-21.

8. Fraser HSF, Long WJ, Naimi S. Evaluation of a cardiac diagnostic program in a typical clinical setting. Journal of the American Medical Inform Association. 2003;10(4):375-81.

9. Gastineau Campos N, Farmer P. Partners: Discernment and humanitarian efforts in settings of violence. Journal of Law, Medicine, and Ethics. 2003;31(4):506-515.

10. Jazayeri D, Farmer P, Mukherjee JS, Léandre F, Fraser HS. An electronic medical record system to support HIV treatment in rural Haiti. American Medical Informatics Association Annual Symposium Proceedings. 2003;878.

11. Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC. From multidrug-resistant tuberculosis to DOTS expansion and beyond: Making the most of a paradigm shift. Tuberculosis. 2003;83:59-65.

12. Kimerling ME, Slavuckij A, Chavers S, Peremtin GG, Tonkel T, Sirotkina O, Golubchikova V, Baddeley A. The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999. Int J Tuberc Lung Dis. 2003;7(9):866-872.

13. Krasnov VA, Kalachev IV, Stepanov DV, Svistel'nik AV, Reviakina OV, Pogozheva LM. [Outlooks for promoting antituberculosis care for the Siberian population][Article in Russian]. Probl Tuberk Bolezn Legk. 2003;(5):3-6.

14. Lipsitch M, Cohen T, Cooper B, Robins J, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M. Transmission dynamics and control of Severe Acute Respiratory Syndrome. Science. 2003;300(5627):1966-1970.

15. Lipsitch M, Murray MB. Multiple equilibria: tuberculosis transmission require unrealistic assumptions [letter to the editor]. Theoretical Population Biology. 2003;63(2):169-170.

16. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Smith Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine. 2003;348(2):119-128.

17. Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Virú FA, Farmer P, Del Castillo HE. Clinical and programmatic considerations in the treatment of MDR-TB in children: A series of 16 patients from Lima, Peru. International Journal of Tuberculosis and Lung Disease. 2003;7(7):637-644.

18. Nardell EA. Environmental infection control of tuberculosis [review]. Seminars in Respiratory Infections. 2003 Dec;18(4):307-19.

19. Nardell EA. Impact of DOTS and DOTS-plus on multidrug resistant TB: DOTS-plus strengthens, not weakens, DOTS programmes [letter]. British Medical Journal. 2003 Jul 19;327(7407):164; author reply 164.

20. Palacios E, Guerra D, Llaro K, Chalco K, Sapag R, Furin J. The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB). International Journal of Tuberculosis and Lung Disease. 2003;7(4):343-346.

21. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. International Journal of Tuberculosis and Lung Disease. 2003;7:912-919.

22. Shin S, Guerra D, Rich M, Seung KJ, Mukherjee J, Joseph K, Hurtado R, Alcántara F, Bayona J, Bonilla C, Farmer P, Furin J. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clinical Infectious Diseases. 2003;36(8):996-1003.

23. Shin SS, Hyson AM, Castaneda C, Sanchez E, Alcántara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. 2003;7(4):347-353.

24. Smith Fawzi MC, Lambert W, Singler JM, Koenig SP, Léandre F, Nevil P, Bertrand D, Claude MS, Bertrand J, Salazar JJ, Louissaint M, Joanis L, Farmer PE. Prevalence and risk factors of STDs in rural Haiti: implications for policy and programming in resource-poor settings. International Journal of STD & AIDS. 2003;14(12):848-853.

2002:

1. Betancourt T. The IRC’s emergency education and recreation for Chechen displaced youth in Ingushetia. Forced Migration Review. 2002;15:28-30.

2. Farmer PE, Gastineau N. Rethinking health and human rights: Time for a paradigm shift. Journal of Law, Medicine, and Ethics. 2002;30(4):655-666.

3. Fraser HS, Jazayeri D, Mitnick CD, Mukherjee JS, Bayona J. Informatics tools to monitor progress and outcomes of patients with drug resistant tuberculosis in Peru. American Medical Informatics Association Annual Symposium Proceedings. 2002;270-274.

4. Gupta R, Cegielski JP, Espinal MA, Henkens M, Kim JY, Lambregts-Van Weezenbeek CS, Lee JW, Raviglione MC, Suarez PG, Varaine F. Increasing transparency in partnerships for health—Introducing the Green Light Committee. Tropical Medicine and International Health. 2002;7(11):970-976.

5. Hughes A, Friedman R, Murray M. Genomewide pattern of synonymous nucleotide substitution in two complete genomes of Mycobacterium tuberculosis. Emerging Infectious Diseases. 2002;8(11):1342-1346.

6. Jacobs B, Clowes C, Wares F, Polivakho V, Lyagoshina T, Peremitin G, Banatvala N. Cost-effectiveness analysis of the Russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia. Int J Tuberc Lung Dis. 2002;6(5):396-405.

7. Kaaya S, Smith Fawzi MC, Mbwambo J, Lee B, Msamanga GI, Fawzi WW. Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatrica Scandinavia. 2002; 106:9-19.

8. Marques EP, Marin HF, Massad E, Fraser H, Ohno-Machado L. Training in health informatics in Brazil. Studies in Health Technology and Informatics. 2002;90:757-60.

9. Miller AC, Butler WR, McInnis B, Boutotte J, Etkind S, Sharnprapai S, Bernardo J, Driscoll J, McGarry M, Crawford JT, Nardell E. Clonal relationships in a shelter-associated outbreak of drug-resistant tuberculosis: 1983-1997. International Journal of Tuberculosis and Lung Disease. 2002;6(10):872-878.

10. Miller AC, Sharnprapai S, Suruki R, Corkren E, Nardell EA, Driscoll JR, McGarry M, Taber H, Etkind S. Impact of genotyping of Mycobacterium tuberculosis on public health practice in Massachusetts. Emerging Infectious Diseases. 2002 Nov;8(11):1285-1289.

11. Mukherjee JS, Shin S, Furin J, Rich ML, Léandre F, Joseph KJ, Seung K, Acha J, Gelmanova I, Goncharova E, Pasechnikov A, Virú FA, Farmer P. New challenges in the clinical management of drug-resistant tuberculosis. Infectious Diseases in Clinical Practice. 2002;11(6):329-339.

12. Murray MB. Determinants of cluster distribution in the molecular epidemiology of tuberculosis. Proceedings of the National Academy of Sciences. 2002;99(3):1538-1543.

13. Murray MB. Molecular epidemiology and the transmission dynamics of TB in the foreign born. Canadian Medical Association Journal. 2002;167(4):355-356.

14. Murray MB, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. American Journal of Epidemiology. 2002;155(6):565-571.

15. Northrup JM, Miller AC, Nardell E, Sharnprapai S, Etkind S, Driscoll J, McGarry M, Taber HW, Elvin P, Qualls NL, Braden CR. Estimated costs of false laboratory diagnoses of tuberculosis in three patients. Emerging Infectious Diseases. 2002 Nov;8(11):1264-1270.

16. Rylko-Bauer B, Farmer P. Managed care or managed inequality? A call for critiques of market-based medicine. Medical Anthropology Quarterly. 2002;16(4):476-502.

17. Sharnprapai S, Miller AC, Suruki R, Corkren E, Etkind S, Driscoll J, McGarry M, Nardell E. Genotyping analyses of tuberculosis cases in U.S.- and foreign-born Massachusetts residents. Emerging Infectious Diseases. 2002 Nov;8(11):1239-1245.

18. Yasin Z, Choi S, Fraser HSF. Improving access to TB medical records in remote clinics in Peru using a personal digital assistant based application. American Medical Informatics Association Annual Symposium Proceedings. 2002;1207.

2001:

1. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, Sax PE, Boswell S, Kahn JO, Brander C, Goulder PJ, Levy JA, Mullins JI, Walker BD. Cellular immune responses and viral diversity in individuals treated during acute and early HIV infection. Journal of Experimental Medicine. 2001;193(2):169-180.

2. Antelman G, Smith Fawzi MC, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, Fawzi WW. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS. 2001 Sep 28;15(14):1865-74.

3. Buka SL, Stichick T, Birdthiste L, Earls F. Youth exposure to violence: prevalence, risks, and consequences. Am J Orthopsychiatry. 2001;71(3), 298.

4. Coley JL, Msamanga GI, Smith Fawzi MC, Kaaya S, Hertzmark E, Kapiga S, Spiegelman D, Hunter D, Fawzi WW. The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania. British Journal of Obstetrics and Gynecology. 2001;108(11):1125-1133.

5. Farmer P, Léandre F, Mukherjee J, Gupta R, Tarter L, Kim JY. Community-based treatment of advanced HIV disease: Introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization. 2001;79(12):1145-1151.

6. Farmer P, Léandre F, Mukherjee JS, Claude MS, Nevil P, Smith Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY. Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001;358(9279):404-409.

7. Farmer P, Rylko-Bauer B. L’“exceptionnel” système de santé américain: Critique d’une médecine à vocation commerciale. Actes de la Recherche en Sciences Sociales. 2001;139:13-30.

8. Fraser HS, Jazayeri D, Bannach L, Szolovits P, McGrath SJ. Telemedmail: free software to facilitate telemedicine in developing countries. Medinfo. 2001;10(Pt 1):815-819.

9. Furin J, Mitnick C, Shin S, Bayona J, Becerra M, Singler J, Alcántara F, Castaneda C, Sanchez E, Acha J, Farmer P, Kim JY. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. 2001;5(7):648-655.

10. Goulder PJR, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, Eldridge RL, Addo MM, He S, Mukherjee JS, Phillips MN, Bunce M, Kalams SA, Sekaly RP, Walker BD, Brander C. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV Infection. Journal of Experimental Medicine. 2001;193(2):181-194.

11. Grange JM, Gandy M, Farmer P, Zumla A. Historical declines in tuberculosis: nature, nurture and the biosocial model. International Journal of Tuberculosis and Lung Disease. 2001;5(3):208-212.

12. Gupta R, Kim JY, Espinal MA, Caudron JM, Pecoul B, Farmer PE, Raviglione MC. Responding to market failures in tuberculosis control. Science. 2001;293(5532):1049-1051.

13. Individual Members of the Harvard Faculty. Consensus statement on antiretroviral treatment for AIDS in poor countries. Topics in HIV Medicine 2001;9(2)14-26.

14. Keshavjee S, Weiser S, Kleinman A. Medicine betrayed: hemophilia patients and HIV in the U.S. Social Science and Medicine. 2001;53(8),1081-1094.

15. Ko G, Burge HA, Nardell EA, Thompson KM. Estimation of tuberculosis risk and incidence under upper room ultraviolet germicidal irradiation in a waiting room in a hypothetical scenario. Risk Analysis. 2001 Aug;21(4):657-673.

16. Mawer C, Ignatenko N, Wares D, Strelis A, Golubchikova V, Yanova G, Lyagoshina T, Sharaburova O, Banatvala N. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. Lancet. 2001;358(9280):445-449.

17. Stichick T. The psychosocial impact of armed conflict on children: rethinking traditional paradigms in research and intervention. Child Adolesc Psychiatr Clin N Am. 2001;10(4):797-814.

18. Raviglione MC, Gupta R, Dye CM, Espinal MA. The burden of drug-resistant tuberculosis and mechanisms for its control. Annals of the New York Academy of Science. 2001;953:88-97.

2000:

1. Becerra MC, Bayona J, Freeman J, Farmer PE, Kim JY. Redefining MDR-TB transmission ‘hot spots’. International Journal of Tuberculosis and Lung Disease. 2000;4(5):387-394.

2. Becerra MC, Freeman J, Bayona J, Shin SS, Furin JJ, Kim JY, Werner B, Timperi R, Sloutsky A, Wilson ME, Pagano M, Farmer PE. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease. 2000;4(2):108-114.

3. Farmer PE. The consumption of the poor: tuberculosis in the 21st century. Ethnography. 2000;1(2):183-216.

4. Field MG, Kotz DM, Bukhman G. Neoliberal economic policy, "state desertion," and the Russian health crisis. In: Kim JY, Millen JV, Irwin A, Gershman J, editors. Dying for growth: global inequality and the health of the poor. Monroe (ME): Common Courage Press, 2000:155-173.

5. Fraser HSF, McGrath SD. Information technology and telemedicine in sub-Saharan Africa. British Medical Journal. 2000;321(7259):465-6.

6. Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. European Journal of Clinical Microbiology and Infectious Disease. 2000;19(2):132-136.

7. Nardell EA. Issues facing TB control (4.1). Nosocomial tuberculosis transmission—problems of health care workers [review]. Scott Med J. 2000 Oct;45(5 Suppl):34-7.

1999:

1. Farmer P. Pathologies of power: rethinking health and human rights. American Journal of Public Health. 1999;89(10):1486-1496.

2. Henry C, Farmer PE. Risk analysis: infections and inequalities in a globalizing era. Development. 1999,42(4):31-34.

3. Nardell EA. Air sampling for tuberculosis: homage to the lowly guinea pig. Chest. 1999;116(4):1143-1145.

4. Subramanyan GS, Yokoe DS, Sharnprapai S, Nardell E, McCray E, Platt R. Using automated pharmacy records to assess the management of tuberculosis. Emerging Infectious Diseases. 1999 Nov-Dec;5(6):788-91.

5. Yokoe DS, Subramanyan GS, Nardell E, Sharnprapai S, McCray E, Platt R. Supplementing tuberculosis surveillance with automated data from health maintenance organizations. Emerging Infectious Diseases. 1999 Nov-Dec;5(6):779-87.

1998:

1. Farmer P, Kim JY. Community-based approaches to the control of multidrug-resistant tuberculosis: Introducing “DOTS-plus.” British Medical Journal. 1998;317(7159):671-674.

2. Fennelly KP, Nardell EA. The relative efficacy of respirators and room ventilation in preventing occupational tuberculosis. Infect Control Hosp Epidemiol. 1998 Oct;19(10):754-759.

3. Mollica RF, McInnes K, Pham T, Smith Fawzi MC, Murphy E, Lin L. The dose-effect relationships between torture and psychiatric symptoms in Vietnamese ex-political detainees and a comparison group. Journal of Nervous and Mental Disease. 1998 Sep;186(9):543-553.

4. Nardell EA. The role of ventilation in preventing nosocomial transmission of tuberculosis. International Journal of Tuberculosis and Lung Disease. 1998;2(9):S110–S117.

5. Nardell EA. Is a tuberculosis exposure a tuberculosis exposure if no one is infected? Infect Control Hosp Epidemiol. 1998 Jul;19(7):484-486.

 

1997:

1. Cohen A, Farmer PE, Kleinman A. Health-behavior interventions: with whom? Health Transition Review. 1997;7(1):81-85.

2. Farmer PE. Social scientists and the new tuberculosis. Social Science and Medicine. 1997;44(3):347-358.

3. Farmer PE, Furin JJ. Sexe, drogue, et violences structurelles: les femmes et le VIH. Journal des Anthropologues. 1997;68-69(35-46): n.p.

4. Furin JJ. You have to be your own doctor: sociocultural influences on alternative therapy use among gay men with AIDS in West Hollywood. Medical Anthropology Quarterly. 1997;11(4):498-504.

5. Singleton L, Turner M, Haskal R, Etkind S, Tricarico M, Nardell E. Long-term hospitalization for tuberculosis control. Experience with a medical-psychosocial inpatient unit. JAMA. 1997 Sep 10;278(10):838-42.

6. Smith Fawzi MC, Murphy E, Pham T, Lin L, Poole C, Mollica RF. The validity of screening for post-traumatic stress disorder and major depression among Vietnamese former political prisoners. Acta Psychiatrica Scandinavica. 1997 Feb;95(2):87-93.

7. Smith Fawzi MC, Pham T, Lin L, Nguyen TV, Ngo D, Murphy E, Mollica RF. The validity of post-traumatic stress disorder among Vietnamese refugees. Journal of Traumatic Stress. 1997;10(1):101-108.

8. Smith Fawzi MC, Aldoori W, Fawzi WW, Armijo-Hussein N. The Gulf War, child nutrition, and feeding practices in Iraq. Nutrition Research. 1997;17(5):775-84.

 

1996:

1. Farmer PE. Haiti’s lost years: Lessons for the Americas. Current Issues in Public Health. 1996;2(3):143-151.

2. Farmer PE. Social inequalities and emerging infectious diseases. Emerging Infectious Diseases. 1996;2(4):259-269.

3. Keshavjee S. Medical anthropology: providing an insight into the social, political and economic determinants of health. Journal of the American Medical Association. 1996;276(13):1096-1097.

4. Nardell EA, Brickner PW. Tuberculosis in New York City: focal transmission of an often fatal disease. JAMA. 1996 Oct 16;276(15):1259-1260.

5. Nardell EA. Needles in haystacks: diagnosing tuberculosis under low prevalence conditions. Tuber Lung Dis. 1996 Oct;77(5):389-390.

1995:

1. Brewer TF, Wilson ME, Nardell EA. BCG immunization: review of past experience, current use, and future prospects. Curr Clin Top Infect Dis. 1995;15:253-270. Review.

2. Korbin JE, Coulton CJ, Furin JJ. A neighborhood-based approach to risk assessment. The APSAC Advisor. 1995;8(4): 9-11.

3. Nardell EA. Interrupting transmission from patients with unsuspected tuberculosis: a unique role for upper-room ultraviolet air disinfection. Am J Infect Control. 1995 Apr;23(2):156-64. Review.

1994:

1. Farmer PE. AIDS-talk and the constitution of cultural models. Social Science and Medicine. 1994;38(6):801-809.

1993:

1. Nardell EA. Environmental control of tuberculosis. Med Clin North Am. 1993 Nov;77(6):1315-1334. Review.

2. Nardell EA. Beyond four drugs. Public health policy and the treatment of the individual patient with tuberculosis. Am Rev Respir Dis. 1993 Jul;148(1):2-5.

3. Nardell EA. Fans, filters, or rays? Pros and cons of the current environmental tuberculosis control technologies. Infect Control Hosp Epidemiol. 1993 Dec;14(12):681-685.

4. Smith M, Zaidi S. Malnutrition in Iraqi children following the Gulf War: Results of a National Survey. Nutrition Reviews. 1993; 51(3):74-78.

1992:

1. Ascherio A, Chase R, Cote T, Dehaes G, Hoskins E, Laaouej J, Passey M, Qaderi S, Shuqaidef S, Smith M, Zaidi S. Effect of the Gulf War on Infant and Child Mortality in Iraq. New England Journal of Medicine. 1992; 327(13):931-936.

2. Nardell EA, Iseman MD, Kubica G, Riley RL, Stead WW, Urbach F. Multidrug-resistant tuberculosis. New England Journal of Medicine. 1992 Oct 15;327(16):1173-1174.

1991:

1. Etkind S, Boutotte J, Ford J, Singleton L, Nardell EA. Treating hard-to-treat tuberculosis patients in Massachusetts. Semin Respir Infect. 1991 Dec;6(4):273-282.

2. Farmer PE, Kim JY. Anthropology, accountability, and the prevention of AIDS. Journal of Sex Research. 1991;28(2):203-221.

3. Farmer PE, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and “compliance”: Lessons from rural Haiti. Seminars in Respiratory Infections. 1991;6(4):254-260.

4. Nardell EA, Keegan J, Cheney SA, Etkind SC. Airborne infection. Theoretical limits of protection achievable by building ventilation. Am Rev Respir Dis. 1991 Aug;144(2):302-306.

5. Nardell EA. Nosocomial tuberculosis in the AIDS era: strategies for interrupting transmission in developed countries. Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep;66(2-3):107-111.

1990:

  1. Farmer PE. Sending sickness: Sorcery, politics, and changing concepts of AIDS in rural Haiti. Medical Anthropology Quarterly. 1990;4(1):6-27.
  2. Farmer PE. The exotic and the mundane: Human Immunodeficiency Virus in Haiti. Human Nature. 1990;1(4):415-446.
  3. Nardell EA. Dodging droplet nuclei. Reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis. 1990 Sep;142(3):501-503.

 

1989:

  1. Farmer PE, Kleinman A. AIDS as human suffering. Dædalus. 1989;118(2):353-378.
  2. Nardell EA. Tuberculosis in homeless, residential care facilities, prisons, nursing homes, and other close communities. Semin Respir Infect. 1989 Sep;4(3):206-15. Review.
  3. Riley RL, Nardell EA. Clearing the air. The theory and application of ultraviolet air disinfection. Am Rev Respir Dis. 1989 May;139(5):1286-1294. Review.

 

1988:

1. Farmer PE. Bad blood, spoiled milk: Body fluids as moral barometers in rural Haiti. American Ethnologist. 1988;15(1):62-83.

2. Farmer PE. Blood, sweat, and baseballs: Haiti in the West Atlantic system. Dialectical Anthropology. 1988;13(1):83-99.

3. Steinberg JL, Nardell EA, Kass EH. Antibiotic prophylaxis after exposure to antibiotic-resistant Mycobacterium tuberculosis. Rev Infect Dis. 1988 Nov-Dec;10(6):1208-19.

1986:

1. Gaines A, Farmer P. Visible saints: Social cynosures and dysphoria in the Mediterranean tradition. Culture, Medicine, and Psychiatry. 1986;10(4):295-330.

2. Nardell E, McInnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. New England Journal of Medicine. 1986;315(25):1570-1575.

 

1985:

1. Patterson WB, Craven DE, Schwartz DA, Nardell EA, Kasmer J, Noble J. Occupational hazards to hospital personnel. Ann Intern Med. 1985 May;102(5):658-680. Review.

 

1982:

1. Nardell EA, Brody JS. Determinants of mechanical properties of rat lung during postnatal development. J Appl Physiol. 1982 Jul;53(1):140-148.

1981:

1. Javaheri S, Nardell EA. Severe metabolic alkalosis: a case report. Br Med J (Clin Res Ed). 1981 Oct 17;283(6298):1016-1017.

2. Nardell EA. Chemotherapy for tuberculosis. Ann Intern Med. 1981 Jan;94(1):138.

1979:

1. Javaheri S, Nardell EA, Kazemi H. Role of PCO2 as determinant of CSF [HCO-3] in metabolic acidosis. Respir Physiol. 1979 Feb;36(2):155-166.

 
Send Feedback   Send Feedback to: Sara Cleveland at scleveland@partners.org
This page was last modified on 8/27/2008